0000899243-15-004962.txt : 20150917 0000899243-15-004962.hdr.sgml : 20150917 20150917173056 ACCESSION NUMBER: 0000899243-15-004962 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150916 FILED AS OF DATE: 20150917 DATE AS OF CHANGE: 20150917 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENXBIO Inc. CENTRAL INDEX KEY: 0001590877 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9712 MEDICAL CENTER DRIVE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 240-552-8181 MAIL ADDRESS: STREET 1: 9712 MEDICAL CENTER DRIVE STREET 2: SUITE 100 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: REGENXBIO, Inc. DATE OF NAME CHANGE: 20150116 FORMER COMPANY: FORMER CONFORMED NAME: ReGenX Biosciences, LLC DATE OF NAME CHANGE: 20131101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Samuels Camille D CENTRAL INDEX KEY: 0001354034 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37553 FILM NUMBER: 151113441 MAIL ADDRESS: STREET 1: 2463 JACKSON ST. CITY: SAN FRANCISCO STATE: CA ZIP: 94115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-16 0 0001590877 REGENXBIO Inc. RGNX 0001354034 Samuels Camille D C/O REGENXBIO INC. 9712 MEDICAL CENTER DRIVE, SUITE 100 ROCKVILLE MD 20850 1 0 0 0 Stock Option (Right to Buy) 22.00 2015-09-16 4 A 0 25000 0.00 A 2025-09-16 Common Stock 25000 25000 D The option will vest in equal monthly installments over the 12 months following September 16, 2015, with immediate full vesting in the event of a change in control. Under an agreement between the reporting person and VR Management, LLC (the "Management Company"), the reporting person is deemed to hold the reported securities for the sole benefit of the Management Company. The Management Company may be deemed the direct beneficial owner of the reported securities, and the reporting person may be deemed the indirect beneficial owner of the reported securities through her interest in the Management Company. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein. /s/ Camille Samuels 2015-09-16